BhattiA. R., DiNinnoV. L., AshtonF. E., WhiteL. A., (1982). A laboratory-acquired infection with
Neisseria meningitidis. Journal of
Infection, 4, 247–252.
2.
BilukhaO. O., RosensteinN. (2005). Prevention and Control of Meningococcal Disease.
Recommendations of the Advisory Committee on Immunization Practices
(ACIP). Morbidity and Mortality Monthly Report—Recommendations
and Reports, 54(RR07), 1–21. Available at www.cdc.gov/mmwr/preview/mmwrhtml/rr5407a1.htm
3.
BoutetR., StuartJ. M., KaczmarskiE. B., GrayS. J., JonesD. M., AndrewsN. (2001). Risk of laboratory-acquired meningococcal
disease. Journal of Hospital Infection, 49(4), 282–284.
Centers for Disease Control and
Prevention. (2002). Laboratory-acquired
meningococcal disease-United States, 2000. Morbidity and
Mortality Weekly Report, 51, 141–144. Available at www.cdc.gov/mmwr/preview/mmwrhtml/mm5107a1.htm
6.
Centers for Disease Control and
Prevention. (1991). Epidemiologic Notes and Reports
Laboratory-Acquired Meningococcemia—California and Massachusetts. Morbidity and Mortality Weekly Report, 40(3), 46–47, 55. Available at www.cdc.gov/mmwr/preview/mmwrhtml/00001882.htm
7.
GuibourdencheM., DarchisJ. P., BoisivonA., CollatzE., RiouJ. Y., (1994). Enzyme electrophoresis, sero- and subtyping, and
outer membrane protein characterization of two Neisseria meningitidis strains
involved in laboratory-acquired infections. Journal
of Clinical Microbiology, 32, 701–704. Available at www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=8195382
SejvarJ. J., JohnsonD., PopovicT., MillerJ. M., DownesF., WeyantP. R., StephensD. S., PerkinsB. A., RosenteinN.
E., (2005). Assessing the
Risk of Laboratory-Acquired Meningococcal Disease. Journal of
Clinical Microbiology, 43(9), 4811–4814. Available at www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=16145146
